{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:34:45Z","timestamp":1782862485991,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1067\/mem.2001.119454","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"660-665","source":"Crossref","is-referenced-by-count":57,"title":["Pentobarbital for severe gamma-butyrolactone withdrawal"],"prefix":"10.1067","volume":"38","author":[{"given":"Marco L.A.","family":"Sivilotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia K.","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mem.2001.119454_bib1","first-page":"184","article-title":"Evolving abuse of GHB in California: bodybuilding drug to date-rape drug [abstract]","volume":"38","author":"Dyer","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1067\/mem.2001.119454_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0196-0644(98)70230-6","article-title":"Clinical course of gamma-hydroxybutyrate overdose","volume":"31","author":"Chin","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0196-0644(99)70320-3","article-title":"Gamma-hydroxybutyrate intoxication and overdose [letter]","volume":"33","author":"Kohrs","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jama.281.11.979","volume":"281","year":"1999","journal-title":"JAMA"},{"key":"10.1067\/mem.2001.119454_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0196-0644(98)70232-X","article-title":"A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management","volume":"31","author":"Li","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.1991.03460040021006","article-title":"Multistate outbreak of poisonings associated with illicit use of gamma-hydroxybutyrate","volume":"265","author":"Centers for Disease Control and Prevention","year":"1991","journal-title":"JAMA"},{"key":"10.1067\/mem.2001.119454_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1997.tb03640.x","article-title":"Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence","volume":"92","author":"Galloway","year":"1997","journal-title":"Addiction"},{"key":"10.1067\/mem.2001.119454_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0196-0644(98)70231-8","article-title":"A tale of novel intoxication: Seven cases of gammahydroxybutyrate acid overdose","volume":"31","author":"Li","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","article-title":"Gamma-hydroxybutyrate: a health-food product producing coma and seizurelike activity","volume":"9","author":"Dyer","year":"1991","journal-title":"Am J Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199809173391215","article-title":"Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a \u201cdietary supplement.\u201d","volume":"339","author":"LoVecchio","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2001.119454_bib11","first-page":"234","article-title":"Gamma-butyrolactone poisoning and its similarities to gamma-hydroxybutyric acid: Two case reports","volume":"39","author":"Rambourg-Schepens","year":"1997","journal-title":"Vet Hum Toxicol"},{"key":"10.1067\/mem.2001.119454_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mem.2001.112985","article-title":"Gamma-hydroxybutyrate withdrawal syndrome","volume":"37","author":"Dyer","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00002826-199901000-00011","article-title":"A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration","volume":"22","author":"Addolorato","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1067\/mem.2001.119454_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1592\/phco.21.2.254.34110","article-title":"Successful management of prolonged gammahydroxybutyrate and alcohol withdrawal","volume":"21","author":"Bowles","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1067\/mem.2001.119454_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0736-4679(99)00163-8","article-title":"Severe gamma-hydroxybutyrate withdrawal: a case report and literature review","volume":"18","author":"Craig","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1553-2712.2000.tb01087.x","article-title":"High-dose intravenous benzodiazepine","volume":"7","author":"Dill","year":"2000","journal-title":"Acad Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addiction"},{"key":"10.1067\/mem.2001.119454_bib18","first-page":"651","article-title":"Gamma-butyrolactone (GBL) withdrawal presenting as acute psychosis [abstract]","volume":"37","author":"Greene","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1067\/mem.2001.119454_bib19","first-page":"535","article-title":"Severe gamma-butyrolactone withdrawal [abstract]","volume":"38","author":"Sharma","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1067\/mem.2001.119454_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(96)00029-9","article-title":"Gamma-hydroxybutyrate is not a GABA agonist","volume":"50","author":"Feigenbaum","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1067\/mem.2001.119454_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0196-0644(99)70320-3","article-title":"Gamma-hydroxybutyrate intoxication and overdose [letter]","volume":"33","author":"Kohrs","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1067\/mem.2001.119454_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/15563659709001236","article-title":"Sites of action of gamma-hydroxybutyrate (GHB)\u2013a neuroactive drug with abuse potential","volume":"35","author":"Tunnicliff","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1067\/mem.2001.119454_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0149-7634(94)90031-0","article-title":"Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and\/or a useful therapeutic agent","volume":"18","author":"Cash","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1067\/mem.2001.119454_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(89)90842-8","article-title":"Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome","volume":"2","author":"Gallimberti","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mem.2001.119454_bib25","first-page":"180","article-title":"Adaptation of \u03b3-aminobutyric acid type A receptors to alcohol exposure: studies with stably transfected cells","volume":"284","author":"Harris","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mem.2001.119454_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1999.8848","article-title":"The role of voltage-gated chloride channels in type II pyrethroid insecticide poisoning","volume":"163","author":"Forshaw","year":"2000","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064401384007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064401384007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T21:41:27Z","timestamp":1576446087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064401384007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0196064401384007"],"URL":"https:\/\/doi.org\/10.1067\/mem.2001.119454","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}